Pediatric Cancer Research Foundation is located in Irvine, CA. The organization was established in 1983. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. As of 12/2023, Pediatric Cancer Research Foundation employed 9 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Pediatric Cancer Research Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Pediatric Cancer Research Foundation generated $4.0m in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 4.5% each year. All expenses for the organization totaled $3.7m during the year ending 12/2023. While expenses have increased by 6.4% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2014, Pediatric Cancer Research Foundation has awarded 151 individual grants totaling $19,242,594. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE FOUNDATION'S MISSION IS TO IMPROVE THE CARE, QUALITY OF LIFE AND SURVIVAL RATE OF CHILDREN WITH MALIGNANT DISEASES. THE FOUNDATION RAISES FUNDS TO SUPPORT STATE-OF-THE-ART RESEARCH THAT WILL ULTIMATELY LEAD TO A CURE FOR ALL CHILDHOOD CANCERS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
PEDIATRIC CANCER RESEARCH ACTIVITIES - PRIMARY FUNDING SOURCE FOR RESEARCH STUDIES, STAFF & EQUIPMENT NEEDS FOR PEDIATRIC CANCER RESEARCH LABS. SEE SCHEDULE I FOR ADDITIONAL DETAIL.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Steve Giusto President | OfficerTrustee | 1 | $0 |
John Weiner Vice-President | OfficerTrustee | 1 | $0 |
Tom Brennan Treasurer | OfficerTrustee | 1 | $0 |
Keith Koeller Secretary | OfficerTrustee | 1 | $0 |
Beth Abrams Director | Trustee | 1 | $0 |
Susie Buchan Director | Trustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $1,764,148 |
Related organizations | $0 |
Government grants | $161,825 |
All other contributions, gifts, grants, and similar amounts not included above | $2,148,375 |
Noncash contributions included in lines 1a–1f | $177,326 |
Total Revenue from Contributions, Gifts, Grants & Similar | $4,074,348 |
Total Program Service Revenue | $0 |
Investment income | $25,508 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $23,830 |
Net Income from Fundraising Events | -$139,194 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $3,984,492 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $1,953,951 |
Grants and other assistance to domestic individuals. | $87,000 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $240,888 |
Compensation of current officers, directors, key employees. | $25,338 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $474,256 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $13,536 |
Payroll taxes | $48,970 |
Fees for services: Management | $0 |
Fees for services: Legal | $9,121 |
Fees for services: Accounting | $74,270 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $288,333 |
Advertising and promotion | $208,498 |
Office expenses | $0 |
Information technology | $14,170 |
Royalties | $0 |
Occupancy | $139,082 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $12,239 |
All other expenses | $0 |
Total functional expenses | $3,727,170 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $933,546 |
Savings and temporary cash investments | $594,253 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $121,345 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $113,268 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $999,710 |
Investments—other securities | $0 |
Investments—program-related | $250,000 |
Intangible assets | $0 |
Other assets | $293,814 |
Total assets | $3,305,936 |
Accounts payable and accrued expenses | $247,474 |
Grants payable | $846,422 |
Deferred revenue | $164,181 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $317,896 |
Total liabilities | $1,575,973 |
Net assets without donor restrictions | $1,729,963 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $3,305,936 |
Over the last fiscal year, Pediatric Cancer Research Foundation has awarded $1,645,724 in support to 15 organizations.
Grant Recipient | Amount |
---|---|
NEW YORK MEDICAL COLLEGE PURPOSE: PEDIATRIC CANCER RESEARCH FOUNDATION LABORATORY AT NEW YORK MEDICAL COLLEGE | $550,000 |
UNIVERSITY OF FLORIDA PURPOSE: INVESTIGATING THE IMMUNE RESPONSE TO RNA-LIPID NANOPARTICLE VACCINES IN A CLINICAL TRIAL FOR CANINES WITH OSTEOSARCOMA | $50,000 |
MAYO CLINIC PURPOSE: TARGETING TRANSCRIPTIONAL DEPENDENCIES IN ATYPICAL TERATOID RHABDOID TUMOR | $50,000 |
NEW YORK UNIVERSITY SCHOOL OF MEDICINE PURPOSE: MODULATING THE IMMUNE MICROENVIRONMENT IN PEDIATRIC ACUTE MYELOID LEUKEMIA | $50,000 |
MD ANDERSON PURPOSE: COMBINING A NOVEL DENDRITIC CELL VACCINE WITH CHECKPOINT BLOCKADE FOR OSTEOSARCOMA THERAPY | $91,717 |
DANA FARBER PURPOSE: PROSPECTIVE VALIDATION OF A PROGNOSTIC LIQUID BIOPSY APPROACH FOR PEDIATRIC EWING SARCOMA | $105,000 |